Neurotech & Neuromodulation · Medical & Healthcare Robotics
Neuralink: Funding & valuation
Funds reporting to the SEC (1) valued their Neuralink stock at $5M as of Jun 2026.
Data updated Nov 22, 2026 · Back to the company report
Financials
Funding rounds, investors and revenue on record.
$1.1BTotal raised
Series ELatest round
3Rounds and grants4 investors
Money by yearUSD, rounds and grants
Largest rounds and grants
Series E
2025
$650M
Series D
2023
$280M
Series C
2021
$205M
Sources: funding announcements, grant and company registers
Money
Funds reporting to the SEC (1) valued their Neuralink stock at $5M as of Jun 2026.
Fund markswhat funds reporting to the SEC say their stakes are worth
Price a share in fund marks, by quarter
Marks by fund: shares held, the price a share, the change since the last quarterPremiumUnlockor this company alone for 30 days · 50 credits
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
